Upgrading Cardiac Care

Nearly 5% of the US population suffers from a cardiac arrhythmia. Current solutions are entirely inadequate to effectively monitor and triage this population. Archimydes is helping AccurKardia build solutions that change this narrative.

AccurKardia announces FDA approval

Our Offerings

Engage our Guild in multiple ways

Product Development

Security

Due Diligence

Startups/Scaleups

Adopt VC assessment techniques for pre-fundraising technical evaluation

VC

Evaluate a startup's technical strengths and risks, comparing it with competitors before investing

Upgrading Cardiac Care

Nearly 5% of the US population suffers from a cardiac arrhythmia. Current solutions are entirely inadequate to effectively monitor and triage this population. Archimydes is helping AccurKardia build solutions that change this narrative.

AccurKardia announces FDA approval

Startups/Scaleups

Adopt VC assessment techniques for pre-fundraising technical evaluation

VC

Evaluate a startup's technical strengths and risks, comparing it with competitors before investing

© 2021. All rights reserved

Privacy Policy Terms & Conditions